Untitled - Roche Trasplantes

BIOPSIA DE PROTOCOLO EN EL TRASPLANTE RENAL
30. Birk PE, Stannard KM, Konrad HB, Blydt-Hansen TD, Ogborn MR, Cheang MS, et al.
Surveillance biopsies are superior to functional studies for the diagnosis of acute and
chronic renal allograft pathology in children. Pediatr Transplant 2004; 8 (1): 29-38.
31. Miyagi M, Ishikawa Y, Mizuiri S, Aikawa A, Ohara T, Hasegawa A. Significance of subclinical
rejection in early renal allograft biopsies for chronic allograft dysfunction. Clin
Transplant 2005; 19 (4): 456-65.
32. Nickerson P, Jeffery J, Gough J, Grimm P, McKenna R, Birk P, et al. Effect of increasing
baseline immunosuppression on the prevalence of clinical and subclinical rejection:
a pilot study. Journal of the American Society of Nephrology 1999; 10 (8):
1801-5.
33. Gloor JM, Cohen AJ, Lager DJ, Grande JP, Fidler ME, Velosa JA, et al. Subclinical rejection
in tacrolimus-treated renal transplant recipients. Transplantation 2002; 73 (12):
1965-8.
34. Kanetsuna Y, Yamaguchi Y, Toma H, Tanabe K. Histological evaluation of renal allograft
protocol biopsies in the early period and 1 year after transplantation. Clin Transplant
2003; 17 Suppl. 10: 25-9.
35. Shishido S, Asanuma H, Nakai H, Mori Y, Satoh H, Kamimaki I, et al. The impact of
repeated subclinical acute rejection on the progression of chronic allograft nephropathy.
J Am Soc Nephrol 2003; 14 (4): 1046-52.
36. Serón D, Moreso F, Bover J, Condom E, Gil-Vernet S, Canas C, et al. Early protocol
renal allograft biopsies and graft outcome. Kidney Int 1997; 51 (1): 310-6.
37. Colvin RB. Chronic allograft nephropathy. N Engl J Med 2003; 349: 2288-90.
38. Nankivell BJ, Borrows RJ, Fung CL-S, O’Connell PJ, Chapman JR, Allen RDMA.
Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology.
Transplantation 2004; 78: 557-65.
39. Myslak M, Amer H, Morales P, Fidler ME, Gloor JM, Larson TS, Stegall MD, Cosio
FG. Interpreting post-transplant proteinuria in patients with proteinuria pre-transplant.
Am J Transplant 2006; 6: 1660-85.
40. Regele H, Bohmig GA, Habicht A, Gollowitzer D, Schillinger M, Rockenschaub S,
Watschinger B, Kerjaschki D, Exner M. Capillary deposition of complement split product
C4d in renal allografts is associated with basement membrane injury in peritubular
and glomerular capillaries: a contribution of humoral immunity to chronic allograft
rejection. J Am Soc Nephrol 2002 Sep; 13 (9): 2371-80.
41. Hamburger J, Crosnier J, Dormont J. Observations in patients with a well tolerated
homotransplant kidney: possibility of a new secondary disease. Ann N Y Acad Sci
1964; 120: 558-77.
42. Racusen L, Colvin RB, Solez K, Mihatsch MJ, Halloran PF, Campbell PM, Cecka MJ,
Cosyns JP, Demetris AJ, Fishbein MC, Fogo A, Furness P, Gibson IW, Glotz D, Hayry P,
Hunsickern L, Kashgarian M, Kerman R, Magil AJ, Montgomery R, Morozumi K, Nickleit
V, Randhawa P, Regele H, Serón D, Seshan S, Sund S, Trpkov K. Antibody-mediated rejection
criteria – an addition to the Banff ’97 classification of renal allograft rejection. Am
J Transplant 2003; 3: 708-14.
28